APR 2014

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link:

Contents of this Issue


Page 14 of 78

EDITORIAL ADVISORY BOARD Mary Lee Amerian, MD Santa Monica Laser and Skin Care Center, Santa Monica, CA Saul R. Berger, MD Medical Director, New Age Aesthetics, Encino, CA Padraic Deighan, MBA, JD, PhD Vail, CO Michael H. Gold, MD Assistant Clinical Professor, Vanderbilt University Medical Center Founder, Gold Skin Care Center, Nashville, TN Bruce Katz, MD Clinical Professor Dermatology, The Mount Sinai School of Medicine Director, Juva Skin & Laser Center, New York Lorrie Klein, MD Assistant Clinical Professor, University of California-Irvine Medical School Founder, LK Dermatology & Laser Center Euro Day Spas, Laguna Niguel, CA Allan Share President, International Medical Spa Association, Minnetonka, MN David H. McDaniel, MD Assistant Professor of Clinical Dermatology and Plastic Surgery, Eastern Virginia Medical School Director, The Institute of Anti-Aging Research, Virginia, Virginia Beach, VA Vic Narurkar, MD Associate Clinical Professor of Dermatology, UC Davis Medical School Chief of Dermatology, California Pacifi c Medical Center, San Francisco Ava Shamban, MD Laser Institute for Dermatology and European Skin Care, Santa Monica, CA Hema Sundaram, MD Director, Dermatology, Cosmetic & Laser Surgery Rockville, MD and Fairfax, VA Wm. Philip Werschler, MD Spokane Dermatology Clinic and Aesthetic Image Medical Spa, Spokane, WA EDITOR'S NOTE • 603.354.3291 10 APRIL 2014 | Med Esthetics As Spring makes its entrance, the medical aesthetics and aesthetic surgery industries continue to bloom. The American Society of Plastic Surgeons (ASPS) released its annual procedural statistics for 2013, which show a 3% increase in cosmetic procedures since 2012. In total, 15.1 million cosmetic surgery procedures—including both minimally invasive and surgical—were performed in the United States last year. The fi ve most requested minimally invasive procedures, which increased 3% to more than 13.4 million in 2013, were: • Botulinum toxin type A (6.3 million injections, up 3%) • Soft tissue fi llers (2.2 million procedures, up 13%) • Chemical peels (1.2 million procedures, up 3%) • Laser hair removal (1.1 million procedures, down 4%) • Microdermabrasion (970,000 procedures, no change) Cosmetic surgical procedures rose 1%, to nearly 1.7 million procedures in 2013. The top fi ve surgical procedures were: • Breast augmentation (290,000 procedures, up 1%) • Rhinoplasty (221,000 procedures, down 9%) • Eyelid surgery (216,000 procedures, up 6%) • Liposuction (200,000 procedures, down 1%) • Facelift (133,000 procedures, up 6%) Despite media reports to the contrary, consumers are not turning away from botulinum toxins. In addition to the growth shown in the ASPS statistics, physicians we spoke with are reporting an increase in demand for Botox Cosmetic, Dysport and Xeomin. On page 34 ("Power of Three"), they share their thoughts on what is fueling the growth and how new product development will affect the neurotoxin market. Key to the growth of the minimally invasive cosmetic market has been the affordability factor—in terms of both downtime and money. For this same reason, women of all ages are drawn to physician-dispensed cosmeceutical products that offer visible skin benefi ts at costs well below lasers and lifts. The challenge for practitioners is how to choose the products and active ingredients that will deliver the results your patients are seeking. On page 42 ("Beyond the Hype"), we offer a review of the six best-proven antiaging ingredients for topical skin care. Physician delegation of laser and injectable treatments allows practices to lower costs to patients and serve a broader audience. But there are steps that must be taken by any practitioner who is delegating medical treatments to ensure patient safety and adherence with regulatory statutes. In "Legal Issues" on page 30, Padraic B. Deighan, JD, PhD, offers a refresher on the roots of physician delegation and how practices can continue this tradition ethically and in the spirit of current regulations. Still Going Strong Inga Hansen Executive Editor/Associate Publisher Despite media reports to the contrary, consumers are not turning away from botulinum toxins. E d i t o r s N o t e M E D 4 1 4 . i n d d 1 0 Editors Note MED414.indd 10 3 / 1 3 / 1 4 9 : 1 5 A M 3/13/14 9:15 AM

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - APR 2014